An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer

Autor:	Samu Kurki, A. Carpelan, Olli Carpén, Raija Ristamäki, Eetu Heervä, Jari Sundström, Vesa Väliaho, Pia Österlund, Arto Rantala, Annika Ålgars, Heikki Minn, T. Salminen, Lasse Nieminen, Heikki Huhtinen
Přispěvatelé:	Tampere University, Department of Oncology, Clinical Medicine, Department of Pathology
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Colorectal cancer 3122 Cancers MEDLINE Cancer specific survival 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine medicine Humans Radiology Nuclear Medicine and imaging Stage (cooking) Neoplasm Staging Hematology Framingham Risk Score Tumor differentiation business.industry General Medicine Prognosis medicine.disease digestive system diseases 3. Good health 030220 oncology & carcinogenesis Colonic Neoplasms business Stage ii colon cancer
Zdroj:	Acta Oncologica. 59:1503-1507
ISSN:	1651-226X 0284-186X
DOI:	10.1080/0284186x.2020.1831062
Popis:	High-risk stage II colon cancer is defined in European and American guidelines as the presence of at least one of the following high-risk factors: T4 stage, tumor differentiation grade 3, bowel obs...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4959afd34158c15b5b0668db99a1f7a8 https://doi.org/10.1080/0284186x.2020.1831062 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.